Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats - Test2 - elhamkhani - TriplyDB

Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats

Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats

http://www.wikidata.org/entity/Q34489018

about

Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS?Oxidative stress and adipocyte biology: focus on the role of AGEs Fatty acid synthase cooperates with glyoxalase 1 to protect against sugar toxicity Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification.Methylglyoxal induces mitochondrial dysfunction and cell death in liver.Dicarbonyl stress and atherosclerosis: is it all RAGE?Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice.Angiogenesis impairment in diabetes: role of methylglyoxal-induced receptor for advanced glycation endproducts, autophagy and vascular endothelial growth factor receptor 2 Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity?Protection from diabetes-induced peripheral sensory neuropathy--a role for elevated glyoxalase I?Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes.L(+) and D(-) lactate are increased in plasma and urine samples of type 2 diabetes as measured by a simultaneous quantification of L(+) and D(-) lactate by reversed-phase liquid chromatography tandem mass spectrometry.Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.Glyoxalase-1 overexpression partially prevents diabetes-induced impaired arteriogenesis in a rat hindlimb ligation model.Pathological significance of mitochondrial glycation Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease Reduced ovarian glyoxalase-I activity by dietary glycotoxins and androgen excess: a causative link to polycystic ovarian syndrome.Advanced glycation end products: Key players in skin aging?Hemolytic and antimalarial effects of tight-binding glyoxalase 1 inhibitors on the host-parasite unit of erythrocytes infected with Plasmodium falciparum.Mild oxidative damage in the diabetic rat heart is attenuated by glyoxalase-1 overexpression Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice.Methylglyoxal in cells elicits a negative feedback loop entailing transglutaminase 2 and glyoxalase 1.Bacterial Responses to Glyoxal and Methylglyoxal: Reactive Electrophilic Species.Methylglyoxal-Glyoxalase 1 Balance: The Root of Vascular Damage.New insights into adipose tissue dysfunction in insulin resistance.Molecular mechanisms for anti-aging by natural dietary compounds.Pathophysiology of diabetic erectile dysfunction: potential contribution of vasa nervorum and advanced glycation endproducts.Endothelial dysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Methylglyoxal and glyoxalase I in atherosclerosis.Reducing methylglyoxal as a therapeutic target for diabetic heart disease.Novel targets of antifibrotic and anti-inflammatory treatment in CKD.The pathobiology of diabetic vascular complications--cardiovascular and kidney disease.Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies.Modulation of GLO1 Expression Affects Malignant Properties of Cells.RAGE and glyoxalase in kidney disease.Methylglyoxal in Metabolic Disorders: Facts, Myths, and Promises.Modulation of GSH with exogenous agents leads to changes in glyoxalase 1 enzyme activity in VL-17A cells exposed to chronic alcohol plus high glucose.Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis.

P2860

Q21560804-AFE35E98-B9CF-41F4-A171-64CD7647BE2C Q26774333-1177BA3F-1EDF-4B3D-942F-6455520A4C63 Q27015039-A89FEF21-2A13-49C9-A132-4AC947F98E37 Q27311488-6D6BA806-8EEA-4557-AAD0-4DAF4E9C2EE7 Q33589073-5E41C313-6961-4A2B-B308-ED9CD620839A Q34389881-E5F48D3A-BEAE-457B-A5B1-82E0497C6C3B Q34393408-B8D35F37-CF0D-4279-9BA8-6E798F0F7214 Q34399952-704498C5-2414-4C68-8E93-5B31322B9F74 Q34441960-1CD37F31-3011-4D44-9032-47B5EFFC1268 Q35578295-EF1B6FFA-BB73-4C71-AE1D-0C94EB71EF8C Q35803421-A85D2BCE-820A-47E5-A546-3259AE14EF4B Q35830289-4E4D570C-CB59-4788-8753-8311ACC34706 Q35845987-3AE2A33A-DDF3-47FA-BC89-51645FEE11BE Q35896615-5934B23F-3128-46B0-837B-77ECE1DEED48 Q36050933-8338AA6C-540C-4ECB-AA31-6BA1D7E04BF1 Q36072507-74772D32-F10C-40E3-8CFB-AE9387FCA72F Q36163917-6CAF24E1-DB1A-4482-81EE-50547E0F198D Q36434349-5A9B5A83-EA58-4201-A528-C471E279DEDC Q36643573-47777719-7961-4942-BB49-57B1278394D1 Q36680620-E2BB9679-7566-4E98-AA3D-6B456C69E95D Q37139085-85D0FF44-F7C3-4ABD-82E1-E0AAC531F5E1 Q37403354-817FC54A-0EBA-4894-BDA6-36580A861CA8 Q37541015-FC231F97-36D9-4FFE-A05D-80360EB5CAED Q37631639-66F434F8-AE16-44FE-BCFC-3E37DC30FEC9 Q37631669-B7090AF1-96FD-49A1-9FEB-E45EC214B62F Q37926599-322B3D24-000A-4AAE-93A4-0D4C4A6C88A8 Q37956231-89E79945-9FD2-40A3-A44C-963B429054C2 Q38036887-F6801849-752C-4BE2-84FA-CA71617403EE Q38082465-56A4C1CD-A420-4B6B-95C9-C5C0DDA4BBC6 Q38096444-18911A52-B095-414D-832E-3E0BF1053772 Q38197343-803D5F7B-0D0A-4734-8CD1-5AFC79A60BAF Q38197358-A23E86E9-DA20-49B7-956D-F8134924F689 Q38198872-FF6D6981-4386-4935-BDE4-97B9A482D4B8 Q38200957-DC36ED5F-41B8-4048-BA17-4478D3A4D864 Q38460480-8130C0CE-76A7-4CCB-886F-99CBCD93BB2B Q38725125-8A8236B6-0D51-4DB6-B929-725B9CF1C14B Q38857649-F9CCD3E5-C555-4399-A1FB-0C7277A6DD62 Q38956425-1C992AE2-E6E2-45CD-B4FF-3DED428DCCEC Q39042002-DB1E468E-F2EA-4AAB-BD9E-22A933584034 Q39096507-D84D4E96-4BC1-4864-B6AA-0C3A87C65653

P2860

Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats

http://www.wikidata.org/entity/Q34489018

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Overexpression of glyoxalase-I ...... dative stress in diabetic rats

@ast

Overexpression of glyoxalase-I ...... dative stress in diabetic rats

@en

Overexpression of glyoxalase-I ...... dative stress in diabetic rats

@nl

type

label

Overexpression of glyoxalase-I ...... dative stress in diabetic rats

@ast

Overexpression of glyoxalase-I ...... dative stress in diabetic rats

@en

Overexpression of glyoxalase-I ...... dative stress in diabetic rats

@nl

prefLabel

Overexpression of glyoxalase-I ...... dative stress in diabetic rats

@ast

Overexpression of glyoxalase-I ...... dative stress in diabetic rats

@en

Overexpression of glyoxalase-I ...... dative stress in diabetic rats

@nl

P1433

Q34489018-2A15C42F-535D-4333-B5AD-2650FB8D5E4D

P1476

Q34489018-D834B58F-4922-4B3F-9C4F-51C5AB4CA7BC

P2093

Q34489018-0C23F61B-617C-43D9-A6F8-558651DAA381

Q34489018-16853EE1-6105-4216-9DB3-1ED7497EEC35

Q34489018-16ABFA86-1E6B-4512-97EA-7D3E4A3AB310

Q34489018-2444636E-8A11-40BA-A9A3-E10FBD268C85

Q34489018-D47AA9B1-6D54-4E37-B771-F484C2271384

Q34489018-D5411BAF-2C86-4DDD-9817-99148F6B1362

Q34489018-E7AD63B6-DA50-47E1-95E6-B9980F88B3C3

P2860

Q34489018-0A61561A-265F-445E-998B-1D08921D16F0

Q34489018-0DA0A4CB-5A9C-4FD6-9F21-A7223DA8FF36

Q34489018-1239BE02-3CE5-41EF-9E40-AF3F68C8B62F

Q34489018-1609B43D-C93D-498C-928E-EE2AC8127C87

Q34489018-1EFD8649-0823-4B75-8B67-A0340E45CB8B

Q34489018-2FD4288E-1981-4B5D-A7E4-31C58E89F901

Q34489018-44AB89A2-EB83-4A5D-AB76-A6A7D0BA7C5D

Q34489018-48DE036A-F034-4404-8AF5-3A8D81710C35

Q34489018-55368052-71BB-4A11-8242-221975B9B6E4

Q34489018-5B3CE399-9258-4BCE-938E-B5BB241ABC8E

P304

Q34489018-1CF94ED8-0053-49E2-87FD-1A098D3208FF

P31

Q34489018-BC7CB873-EAF3-4580-8809-507CB61B8AEF

P356

Q34489018-6A4CFD2A-A64E-4D32-B3D6-5467C5F7F0DC

P407

Q34489018-E0C8B7B9-0255-41A8-A9A3-B59C661A2DC0

P433

Q34489018-270626DB-4CC5-4C16-8D7A-8E8B152D8DE5

P478

Q34489018-8540C20B-EB22-4A93-820E-B14E8F0AF075

P50

Q34489018-73A3DF41-06D6-4570-B2A8-550DBCA61507

Q34489018-7FB7D476-811C-44CE-9E28-15534FA82ECF

Q34489018-EB39D090-7C69-4FE1-87C4-DF071B07F1DE

P577

Q34489018-B7389B49-81E6-4E16-B821-CF180182FA2C

P5875

Q34489018-65B64057-7462-447E-BD30-85EEBF8D71B7

P698

Q34489018-4E2298D1-E209-485C-B0BC-CCBF0FA6B6F9

P921

Q34489018-82FCF266-77A1-4422-8C1E-531424733550

Q34489018-9A43BFA4-4414-492C-BBF9-D7F3DA1B7824

P932

Q34489018-BCDAC232-B756-47BD-8189-8A0E9AE476C6

P356

JBC.M110.144097

P1433

Journal of Biological Chemistry

P1476

Overexpression of glyoxalase-I ...... dative stress in diabetic rats

@en

P2093

Coen D Stehouwer

http://www.w3.org/2001/XMLSchema#string

Michael Brownlee

http://www.w3.org/2001/XMLSchema#string

Olaf Brouwers

http://www.w3.org/2001/XMLSchema#string

Peter G Scheffer

http://www.w3.org/2001/XMLSchema#string

Petra M Niessen

http://www.w3.org/2001/XMLSchema#string

Tom Teerlink

http://www.w3.org/2001/XMLSchema#string

Toshio Miyata

http://www.w3.org/2001/XMLSchema#string

P2860

Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis

Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis

Biochemistry and molecular cell biology of diabetic complications

Glyoxalase I--structure, function and a critical role in the enzymatic defence against glycation

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

Glyoxalase I – structure, function and a critical role in the enzymatic defence against glycation

Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress

Nonenzymatic browning in vivo: possible process for aging of long-lived proteins.

Alpha-oxoaldehyde metabolism and diabetic complications.

P304

1374-1380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M110.144097

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

286

http://www.w3.org/2001/XMLSchema#string

P50

Patrick Schrauwen

Isabel Ferreira

Casper G. Schalkwijk

P577

2010-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47700901

http://www.w3.org/2001/XMLSchema#string

P698

21056979

http://www.w3.org/2001/XMLSchema#string

P921

P932

3020745

http://www.w3.org/2001/XMLSchema#string